We are live on ! Find out more
OPXAW

Opexa Therapeutics, Inc.
OPXAW

Delisted

OPXAW was delisted on the 20th of September, 2017.

Back to rankings

4 hedge funds and large institutions have $134K invested in Opexa Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more capital invested

Capital invested by funds: $38K → $134K (+$96K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

33% less funds holding

Funds holding: 6 → 4 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$24.9K
2
TSS
Two Sigma Securities
New York
+$6.73K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$27K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$1.97K
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
1
Virtu KCG Holdings
New York
$79K +$24.9K +670,753 +1,358%
California Public Employees Retirement System
2
California Public Employees Retirement System
California
$29K – – –
TSS
3
Two Sigma Securities
New York
$20K +$6.73K +181,400 New
Bank of New York Mellon
4
Bank of New York Mellon
New York
$6K -$1.97K -53,110 -52%
Millennium Management
5
Millennium Management
New York
– -$27K -1,600,000 Closed
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
– -$4K -256,572 Closed

OPXAW Hedge Fund Activity: Q2 2017 in Review

4 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Opexa Therapeutics, Inc. (OPXAW) for Q2 2017, worth a combined $134K — up 253% from $38K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of OPXAW and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Virtu KCG Holdings, adding an estimated $24.9K. The largest seller was Millennium Management, exiting entirely with an estimated $27K sold.

  • 4 institutional investors held Opexa Therapeutics, Inc. (OPXAW) as of Q2 2017, down from 6 in Q1 2017.
  • Funds reported $134K of Opexa Therapeutics, Inc. stock for Q2 2017, up 253% quarter-over-quarter.
  • 1 fund opened new Opexa Therapeutics, Inc. positions in Q2 2017 and 3 closed out, a net change of -2 holders.
  • The largest Opexa Therapeutics, Inc. buyer in Q2 2017 was Virtu KCG Holdings, an estimated $24.9K added.
  • The largest Opexa Therapeutics, Inc. seller in Q2 2017 was Millennium Management, an estimated $27K sold.

Based on aggregated 13F filings for Q2 2017.